A phase II, open label trial in treatment naive, HIV 1 infected subjects who will receive TMC114/Rtv as a monotherapy
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2010
At a glance
- Drugs Darunavir; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Janssen R&D Ireland
- 31 Aug 2018 Biomarkers information updated
- 24 Apr 2008 Status changed from in progress to discontinued, reported by ClinicalTrials.gov. The study was terminated due to poor recruitment.
- 24 Mar 2008 New trial record.